👉 In this #ESMODeepDive, we explore the evolving treatment landscape in relapsed #OvarianCancer, from changing concepts of platinum-sensitive relapse to the role of antibody-drug conjugates and therapeutic sequencing

🔗ESMO members: https://ow.ly/BpFL50ZTT4J

#ESMOOnAir

👉 In this #ESMOOnAir webinar, we focus on optimising antibody-drug conjugate safety, from prevention and risk mitigation to the recognition and management of ADC-related ILD and ocular toxicity

🔗 https://ow.ly/77er50ZIEBB